SN

Shabas Najeev

Active Director Director DIN 10384310
DIN 10384310 First appointment Nov 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Shabas Najeev

Data last updated:

Shabas Najeev is a Director at Alsaz Hospitals Private Limited (since 2023). The company operates in Healthcare.

DIN 10384310
Primary Designation Director
Industry Healthcare
First Appointment 07 Nov 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alsaz Hospitals Private Limited U86909KL2023PTC084411
Director07 Nov 20232023Active

Board colleagues of Shabas Najeev

NameDINCompanyDesignation
Afeez Hassan10384309Alsaz Hospitals Private LimitedManaging Director
Shafeer Sainulabdeen10384311Alsaz Hospitals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alsaz Hospitals Private Limited
Premium access

Shareholding and investment profile for Shabas Najeev

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shabas Najeev

Shabas Najeev currently holds 1 directorship: Alsaz Hospitals Private Limited (Director, since 07 Nov 2023).

Shabas Najeev was first appointed on 07 Nov 2023 as Director at Alsaz Hospitals Private Limited.

The current boards of Shabas Najeev's companies include Afeez Hassan (Alsaz Hospitals Private Limited), Shafeer Sainulabdeen (Alsaz Hospitals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available